4.6 Article

Mechanism for oral tumor cell lysyl oxidase like-2 in cancer development: synergy with PDGF-AB

Journal

ONCOGENESIS
Volume 8, Issue -, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/s41389-019-0144-0

Keywords

-

Categories

Funding

  1. Pharmaxis Ltd., Frenchs Forest, NSW, Australia
  2. Evans Center for Interdisciplinary Biomedical Research ARC on the Etiology and Pathogenesis of Oral Cancer at Boston University
  3. Boston University School of Dental Medicine
  4. NIH/NIDCR [R21 DE023973]
  5. NIH-NCRR [S10RR024523]

Ask authors/readers for more resources

Extracellular lysyl oxidases (LOX and LOXL1-LOXL4) are critical for collagen biosynthesis. LOXL2 is a marker of poor survival in oral squamous cell cancer. We investigated mechanisms by which tumor cell secreted LOXL2 targets proximal mesenchymal cells to enhance tumor growth and metastasis. This study identified the first molecular mechanism for LOXL2 in the promotion of cancer via its enzymatic modification of a non-collagenous substrate in the context of paracrine signaling between tumor cells and resident fibroblasts. The role and mechanism of active LOXL2 in promoting oral cancer was evaluated and employed a novel LOXL2 small molecule inhibitor, PSX-S1C, administered to immunodeficient, and syngeneic immunocompetent orthotopic oral cancer mouse models. Tumor growth, histopathology, and metastases were monitored. In vitro mechanistic studies with conditioned tumor cell medium treatment of normal human oral fibroblasts were carried out in the presence and absence of the LOXL2 inhibitor to identify signaling mechanisms promoted by LOXL2 activity. Inhibition of LOXL2 attenuated cancer growth and lymph node metastases in the orthotopic tongue mouse models. Immunohistochemistry data indicated that LOXL2 expression in and around tumors was decreased in mice treated with the inhibitor. Inhibition of LOXL2 activity by administration of PXS-S1C to mice reduced tumor cell proliferation, accompanied by changes in morphology and in the expression of epithelial to mesenchymal transition markers. In vitro studies identified PDGFR beta as a direct substrate for LOXL2, and indicated that LOXL2 and PDGF-AB together secreted by tumor cells optimally activated PDGFR beta in fibroblasts to promote proliferation and the tendency toward fibrosis via ERK activation, but not AKT. Optimal fibroblast proliferation in vitro required LOXL2 activity, while tumor cell proliferation did not. Thus, tumor cell-derived LOXL2 in the microenvironment directly targets neighboring resident cells to promote a permissive local niche, in addition to its known role in collagen maturation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Cell Biology

Functional importance of lysyl oxidase family propeptide regions

Philip C. Trackman

JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)

Article Oncology

A polymorphism in the lysyl oxidase propeptide domain accelerates carcinogen-induced cancer

Ana de la Cueva, Michael Emmerling, Sarah L. Lim, Shi Yang, Philip C. Trackman, Gail E. Sonenshein, Kathrin H. Kirsch

CARCINOGENESIS (2018)

Article Dentistry, Oral Surgery & Medicine

Multiple Functions of Lysyl Oxidase Like-2 in Oral Fibroproliferative Processes

D. Saxena, F. Mahjour, A. D. Findlay, E. A. Mously, A. Kantarci, P. C. Trackman

JOURNAL OF DENTAL RESEARCH (2018)

Article Dentistry, Oral Surgery & Medicine

Oral Sciences PhD Program Enrollment, Graduates, and Placement: 1994 to 2016

C. R. Herzog, D. W. Berzins, P. DenBesten, R. L. Gregory, K. M. Hargreaves, R. L. W. Messer, M. Mina, M. P. Mooney, M. L. Paine, C. Phillips, R. B. Presland, R. G. Quivey, F. A. Scannapieco, J. F. Sheridan, K. K. H. Svoboda, P. C. Trackman, M. P. Walker, S. G. Walker, C. Y. Wang, J. C. C. Hu

JOURNAL OF DENTAL RESEARCH (2018)

Meeting Abstract Oncology

Lysyl oxidase like-2 mediates tumor to stromal cell communication in oral cancer

Faranak Mahjour, Philip C. Trackman

CANCER RESEARCH (2018)

Article Pathology

Effects of High Glucose-Induced Lysyl Oxidase Propeptide on Retinal Endothelial Cell Survival Implications for Diabetic Retinopathy

Dongjoon Kim, Dayeun Lee, Philip C. Trackman, Sayon Roy

AMERICAN JOURNAL OF PATHOLOGY (2019)

Review Biochemistry & Molecular Biology

Functions and Mechanisms of Pro-Lysyl Oxidase Processing in Cancers and Eye Pathologies with a Focus on Diabetic Retinopathy

Philip C. Trackman, Yaser Peymanfar, Sayon Roy

Summary: Lysyl oxidases are multifunctional proteins involved in the biosynthesis and maturation of connective tissues. Their overexpression is associated with fibrosis and cancer, while their propeptide has tumor-suppressing effects. In diabetic retinopathy, lysyl oxidases are overexpressed and their propeptide levels are elevated. Further research is needed to understand the activities and mechanisms of lysyl oxidase propeptide.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

The Lysyl Oxidase G473A Polymorphism Exacerbates Oral Cancer Development in Humans and Mice

Yaser Peymanfar, Faranak Mahjour, Neha Shrestha, Ana de la Cueva, Ying Chen, Shengyuan Huang, Kathrin H. Kirsch, Xiaozhe Han, Philip C. Trackman

Summary: Oral cancer, primarily squamous-cell carcinoma with a 5-year survival rate of approximately 50%, is more common in humans carrying a polymorphism in the propeptide region of lysyl oxidase (LOX). Knockin mice carrying the same polymorphism are more susceptible to lesion development. The presence of wildtype LOX-PP in humans and mice has a tumor-inhibitory effect.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Editorial Material Biochemistry & Molecular Biology

Multifunctional Lysyl Oxidases

Philip C. C. Trackman

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Endocrinology & Metabolism

β-Catenin mediates glucose-dependent insulinotropic polypeptide increases in lysyl oxidase expression in osteoblasts

Eileen J. Daley, Philip C. Trackman

Summary: This study reveals the mechanism by which GIP regulates LOX expression, mediated by beta-catenin. These findings provide important insights for designing potential therapeutic approaches to address deficient LOX production in diabetic bone disease by suggesting exploring strategies to stimulate beta-catenin signaling in osteoblasts under diabetic conditions as potential therapeutic strategies.

BONE REPORTS (2021)

Meeting Abstract Ophthalmology

High Glucose Increases Binding of Lysyl Oxidase with Extracellular Matrix Proteins in Retinal Endothelial Cells: Implications for Diabetic Retinopathy

Ngan Ha Nguyen, Dongjoon Kim, Philip C. Trackman, Sayon Roy

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2019)

Article Endocrinology & Metabolism

Impaired Gastric Hormone Regulation of Osteoblasts and Lysyl Oxidase Drives Bone Disease in Diabetes Mellitus

Eileen J. Daley, Paola Divieti Pajevic, Sayon Roy, Philip C. Trackman

JBMR PLUS (2019)

Article Medicine, Research & Experimental

Intracellular retention of mutant lysyl oxidase leads to aortic dilation in response to increased hemodynamic stress

Vivian S. Lee, Carmen M. Halabi, Thomas J. Broekelmann, Philip C. Trackman, Nathan O. Stitziel, Robert P. Mecham

JCI INSIGHT (2019)

Meeting Abstract Ophthalmology

Role of high glucose-induced lysyl oxidase overexpression on Ras activity in rat retinal endothelial cells

Brian Chirn, Dongjoon Kim, Philip C. Trackman, Sayon Roy

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)

No Data Available